PT Enseval Putera Megatrading Tbk. (EPMT.JK)
IDR 2360.0
(0.0%)
IDR 2360.0
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.36 Billion IDR | -18.84% |
| 2022 | 2.91 Billion IDR | -67.9% |
| 2021 | 9.07 Billion IDR | -15.04% |
| 2020 | 10.68 Billion IDR | 0.0% |
| 2019 | - IDR | 0.0% |
| 2018 | - IDR | 0.0% |
| 2017 | - IDR | 0.0% |
| 2016 | - IDR | 0.0% |
| 2015 | - IDR | 0.0% |
| 2014 | - IDR | 0.0% |
| 2013 | - IDR | 0.0% |
| 2012 | - IDR | 0.0% |
| 2011 | - IDR | 0.0% |
| 2010 | - IDR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | - IDR | -10.1% |
| 2024 Q1 | 2.16 Billion IDR | -8.4% |
| 2024 Q2 | 1.96 Billion IDR | -9.17% |
| 2023 Q2 | 2.7 Billion IDR | -6.85% |
| 2023 Q1 | 2.89 Billion IDR | -0.53% |
| 2023 Q4 | 2.36 Billion IDR | -5.45% |
| 2023 FY | 2.36 Billion IDR | -18.84% |
| 2023 Q3 | 2.5 Billion IDR | -7.36% |
| 2022 Q3 | 3.11 Billion IDR | 0.0% |
| 2022 Q4 | 2.91 Billion IDR | -6.38% |
| 2022 FY | 2.91 Billion IDR | -67.9% |
| 2022 Q1 | 9.47 Billion IDR | 4.31% |
| 2022 Q2 | - IDR | -100.0% |
| 2021 Q2 | 13.28 Billion IDR | 0.33% |
| 2021 Q1 | 13.24 Billion IDR | 23.93% |
| 2021 Q4 | 9.07 Billion IDR | -27.07% |
| 2021 FY | 9.07 Billion IDR | -15.04% |
| 2021 Q3 | 12.44 Billion IDR | -6.32% |
| 2020 Q1 | 419.62 Million IDR | 0.0% |
| 2020 Q3 | 13.05 Billion IDR | 2183.93% |
| 2020 Q4 | 10.68 Billion IDR | -18.16% |
| 2020 FY | 10.68 Billion IDR | 0.0% |
| 2020 Q2 | 571.75 Million IDR | 36.25% |
| 2019 Q3 | - IDR | 0.0% |
| 2019 FY | - IDR | 0.0% |
| 2019 Q4 | - IDR | 0.0% |
| 2019 Q2 | - IDR | 0.0% |
| 2019 Q1 | - IDR | 0.0% |
| 2018 Q1 | - IDR | 0.0% |
| 2018 Q2 | - IDR | 0.0% |
| 2018 Q3 | - IDR | 0.0% |
| 2018 FY | - IDR | 0.0% |
| 2018 Q4 | - IDR | 0.0% |
| 2017 Q3 | - IDR | 0.0% |
| 2017 Q1 | - IDR | 0.0% |
| 2017 Q2 | - IDR | 0.0% |
| 2017 Q4 | - IDR | 0.0% |
| 2017 FY | - IDR | 0.0% |
| 2016 FY | - IDR | 0.0% |
| 2016 Q2 | - IDR | 0.0% |
| 2016 Q3 | - IDR | 0.0% |
| 2016 Q4 | - IDR | 0.0% |
| 2016 Q1 | - IDR | 0.0% |
| 2015 Q3 | - IDR | 0.0% |
| 2015 Q2 | - IDR | 0.0% |
| 2015 Q1 | - IDR | 0.0% |
| 2015 FY | - IDR | 0.0% |
| 2015 Q4 | - IDR | 0.0% |
| 2014 Q2 | - IDR | 0.0% |
| 2014 Q4 | - IDR | 0.0% |
| 2014 FY | - IDR | 0.0% |
| 2014 Q3 | - IDR | 0.0% |
| 2014 Q1 | - IDR | 0.0% |
| 2013 FY | - IDR | 0.0% |
| 2013 Q2 | - IDR | 0.0% |
| 2013 Q1 | - IDR | 0.0% |
| 2013 Q3 | - IDR | 0.0% |
| 2013 Q4 | - IDR | 0.0% |
| 2012 Q3 | - IDR | 0.0% |
| 2012 Q4 | - IDR | 0.0% |
| 2012 FY | - IDR | 0.0% |
| 2011 FY | - IDR | 0.0% |
| 2010 FY | - IDR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| PT Itama Ranoraya Tbk | 502.93 Million IDR | -370.288% |
| PT Kimia Farma (Persero) Tbk | 972.97 Billion IDR | 99.757% |
| PT Millennium Pharmacon International Tbk | 44 Billion IDR | 94.624% |
| PT Soho Global Health Tbk | 9.44 Billion IDR | 74.944% |